nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—Tetany—Riluzole—amyotrophic lateral sclerosis	0.043	0.0692	CcSEcCtD
Furosemide—SLC12A1—appendage—amyotrophic lateral sclerosis	0.0279	0.113	CbGeAlD
Furosemide—Thrombosis—Riluzole—amyotrophic lateral sclerosis	0.0198	0.0319	CcSEcCtD
Furosemide—Apathy—Riluzole—amyotrophic lateral sclerosis	0.0196	0.0316	CcSEcCtD
Furosemide—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.0194	0.0313	CcSEcCtD
Furosemide—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.0174	0.028	CcSEcCtD
Furosemide—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.0173	0.0278	CcSEcCtD
Furosemide—Gout—Riluzole—amyotrophic lateral sclerosis	0.015	0.0241	CcSEcCtD
Furosemide—CA1—nerve—amyotrophic lateral sclerosis	0.0136	0.0553	CbGeAlD
Furosemide—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.0132	0.0212	CcSEcCtD
Furosemide—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.0129	0.0207	CcSEcCtD
Furosemide—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.0122	0.0196	CcSEcCtD
Furosemide—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.0117	0.0188	CcSEcCtD
Furosemide—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.0116	0.0186	CcSEcCtD
Furosemide—Deafness—Riluzole—amyotrophic lateral sclerosis	0.0114	0.0183	CcSEcCtD
Furosemide—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.0114	0.0183	CcSEcCtD
Furosemide—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0173	CcSEcCtD
Furosemide—Thirst—Riluzole—amyotrophic lateral sclerosis	0.0107	0.0172	CcSEcCtD
Furosemide—CA4—nerve—amyotrophic lateral sclerosis	0.0107	0.0432	CbGeAlD
Furosemide—Purpura—Riluzole—amyotrophic lateral sclerosis	0.0106	0.017	CcSEcCtD
Furosemide—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0169	CcSEcCtD
Furosemide—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0164	CcSEcCtD
Furosemide—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00967	0.0156	CcSEcCtD
Furosemide—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00946	0.0152	CcSEcCtD
Furosemide—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00929	0.0149	CcSEcCtD
Furosemide—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00926	0.0149	CcSEcCtD
Furosemide—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00897	0.0144	CcSEcCtD
Furosemide—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00885	0.0142	CcSEcCtD
Furosemide—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00862	0.0139	CcSEcCtD
Furosemide—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00812	0.0131	CcSEcCtD
Furosemide—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00803	0.0129	CcSEcCtD
Furosemide—CA4—hindbrain—amyotrophic lateral sclerosis	0.00798	0.0324	CbGeAlD
Furosemide—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00752	0.0121	CcSEcCtD
Furosemide—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00741	0.0119	CcSEcCtD
Furosemide—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00732	0.0118	CcSEcCtD
Furosemide—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00695	0.0112	CcSEcCtD
Furosemide—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.0069	0.0111	CcSEcCtD
Furosemide—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00665	0.0107	CcSEcCtD
Furosemide—CA2—hindbrain—amyotrophic lateral sclerosis	0.00662	0.0268	CbGeAlD
Furosemide—CA14—medulla oblongata—amyotrophic lateral sclerosis	0.0066	0.0268	CbGeAlD
Furosemide—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00658	0.0106	CcSEcCtD
Furosemide—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00638	0.0103	CcSEcCtD
Furosemide—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00636	0.0102	CcSEcCtD
Furosemide—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00629	0.0101	CcSEcCtD
Furosemide—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00613	0.00986	CcSEcCtD
Furosemide—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00604	0.00971	CcSEcCtD
Furosemide—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.006	0.00965	CcSEcCtD
Furosemide—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00589	0.00948	CcSEcCtD
Furosemide—CA14—spinal cord—amyotrophic lateral sclerosis	0.00589	0.0239	CbGeAlD
Furosemide—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00566	0.00911	CcSEcCtD
Furosemide—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00563	0.00906	CcSEcCtD
Furosemide—CA7—cerebellum—amyotrophic lateral sclerosis	0.00561	0.0227	CbGeAlD
Furosemide—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.0055	0.00886	CcSEcCtD
Furosemide—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00548	0.00882	CcSEcCtD
Furosemide—SLC12A1—spinal cord—amyotrophic lateral sclerosis	0.00529	0.0215	CbGeAlD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00518	0.00833	CcSEcCtD
Furosemide—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.0051	0.00821	CcSEcCtD
Furosemide—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00504	0.00811	CcSEcCtD
Furosemide—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.005	0.00804	CcSEcCtD
Furosemide—CA9—cerebellum—amyotrophic lateral sclerosis	0.00492	0.02	CbGeAlD
Furosemide—Shock—Riluzole—amyotrophic lateral sclerosis	0.00492	0.00791	CcSEcCtD
Furosemide—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.0049	0.00789	CcSEcCtD
Furosemide—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.0049	0.00788	CcSEcCtD
Furosemide—PGD—medulla oblongata—amyotrophic lateral sclerosis	0.00488	0.0198	CbGeAlD
Furosemide—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00486	0.00781	CcSEcCtD
Furosemide—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00483	0.00778	CcSEcCtD
Furosemide—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00477	0.00767	CcSEcCtD
Furosemide—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00467	0.00752	CcSEcCtD
Furosemide—CA14—cerebellum—amyotrophic lateral sclerosis	0.00467	0.0189	CbGeAlD
Furosemide—CA4—brainstem—amyotrophic lateral sclerosis	0.00457	0.0186	CbGeAlD
Furosemide—CA7—brain—amyotrophic lateral sclerosis	0.00455	0.0185	CbGeAlD
Furosemide—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00449	0.00722	CcSEcCtD
Furosemide—SLC12A1—nervous system—amyotrophic lateral sclerosis	0.00446	0.0181	CbGeAlD
Furosemide—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00444	0.00715	CcSEcCtD
Furosemide—PGD—spinal cord—amyotrophic lateral sclerosis	0.00435	0.0176	CbGeAlD
Furosemide—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00435	0.00699	CcSEcCtD
Furosemide—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00432	0.00694	CcSEcCtD
Furosemide—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00431	0.00694	CcSEcCtD
Furosemide—SLC12A1—central nervous system—amyotrophic lateral sclerosis	0.00429	0.0174	CbGeAlD
Furosemide—Pain—Riluzole—amyotrophic lateral sclerosis	0.00428	0.00688	CcSEcCtD
Furosemide—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00428	0.00688	CcSEcCtD
Furosemide—CA2—embryo—amyotrophic lateral sclerosis	0.00414	0.0168	CbGeAlD
Furosemide—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00412	0.00663	CcSEcCtD
Furosemide—SLCO2A1—nervous system—amyotrophic lateral sclerosis	0.00411	0.0167	CbGeAlD
Furosemide—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00409	0.00658	CcSEcCtD
Furosemide—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00397	0.00639	CcSEcCtD
Furosemide—SLCO2A1—central nervous system—amyotrophic lateral sclerosis	0.00396	0.0161	CbGeAlD
Furosemide—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00395	0.00636	CcSEcCtD
Furosemide—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00395	0.00636	CcSEcCtD
Furosemide—CA12—nervous system—amyotrophic lateral sclerosis	0.00387	0.0157	CbGeAlD
Furosemide—CA14—brain—amyotrophic lateral sclerosis	0.00379	0.0154	CbGeAlD
Furosemide—CA2—brainstem—amyotrophic lateral sclerosis	0.00379	0.0154	CbGeAlD
Furosemide—CA12—central nervous system—amyotrophic lateral sclerosis	0.00373	0.0151	CbGeAlD
Furosemide—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00368	0.00593	CcSEcCtD
Furosemide—PGD—nervous system—amyotrophic lateral sclerosis	0.00367	0.0149	CbGeAlD
Furosemide—CA1—spinal cord—amyotrophic lateral sclerosis	0.00364	0.0148	CbGeAlD
Furosemide—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00359	0.00577	CcSEcCtD
Furosemide—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00354	0.00569	CcSEcCtD
Furosemide—PGD—central nervous system—amyotrophic lateral sclerosis	0.00353	0.0143	CbGeAlD
Furosemide—CA5B—nervous system—amyotrophic lateral sclerosis	0.00347	0.0141	CbGeAlD
Furosemide—PGD—cerebellum—amyotrophic lateral sclerosis	0.00345	0.014	CbGeAlD
Furosemide—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00342	0.0055	CcSEcCtD
Furosemide—SLC12A1—brain—amyotrophic lateral sclerosis	0.00341	0.0138	CbGeAlD
Furosemide—CA5B—central nervous system—amyotrophic lateral sclerosis	0.00334	0.0136	CbGeAlD
Furosemide—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00331	0.00532	CcSEcCtD
Furosemide—SLC22A6—brain—amyotrophic lateral sclerosis	0.0033	0.0134	CbGeAlD
Furosemide—CA4—medulla oblongata—amyotrophic lateral sclerosis	0.00319	0.0129	CbGeAlD
Furosemide—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00318	0.00511	CcSEcCtD
Furosemide—Rash—Riluzole—amyotrophic lateral sclerosis	0.00315	0.00507	CcSEcCtD
Furosemide—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00315	0.00507	CcSEcCtD
Furosemide—SLCO2A1—brain—amyotrophic lateral sclerosis	0.00314	0.0128	CbGeAlD
Furosemide—Headache—Riluzole—amyotrophic lateral sclerosis	0.00313	0.00504	CcSEcCtD
Furosemide—CA1—nervous system—amyotrophic lateral sclerosis	0.00307	0.0124	CbGeAlD
Furosemide—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00297	0.00478	CcSEcCtD
Furosemide—CA12—brain—amyotrophic lateral sclerosis	0.00296	0.012	CbGeAlD
Furosemide—CA1—central nervous system—amyotrophic lateral sclerosis	0.00295	0.012	CbGeAlD
Furosemide—CA4—spinal cord—amyotrophic lateral sclerosis	0.00284	0.0115	CbGeAlD
Furosemide—PGD—brain—amyotrophic lateral sclerosis	0.0028	0.0114	CbGeAlD
Furosemide—CA5B—brain—amyotrophic lateral sclerosis	0.00265	0.0108	CbGeAlD
Furosemide—CA2—medulla oblongata—amyotrophic lateral sclerosis	0.00264	0.0107	CbGeAlD
Furosemide—SLC22A5—medulla oblongata—amyotrophic lateral sclerosis	0.0026	0.0106	CbGeAlD
Furosemide—SLC22A8—nervous system—amyotrophic lateral sclerosis	0.00259	0.0105	CbGeAlD
Furosemide—SLC22A8—central nervous system—amyotrophic lateral sclerosis	0.00249	0.0101	CbGeAlD
Furosemide—CA4—nervous system—amyotrophic lateral sclerosis	0.0024	0.00972	CbGeAlD
Furosemide—CA2—spinal cord—amyotrophic lateral sclerosis	0.00236	0.00957	CbGeAlD
Furosemide—CA1—brain—amyotrophic lateral sclerosis	0.00234	0.00951	CbGeAlD
Furosemide—SLC22A5—spinal cord—amyotrophic lateral sclerosis	0.00232	0.00941	CbGeAlD
Furosemide—CA4—central nervous system—amyotrophic lateral sclerosis	0.00231	0.00936	CbGeAlD
Furosemide—CA4—cerebellum—amyotrophic lateral sclerosis	0.00226	0.00915	CbGeAlD
Furosemide—ALB—brain—amyotrophic lateral sclerosis	0.00206	0.00835	CbGeAlD
Furosemide—CA2—nervous system—amyotrophic lateral sclerosis	0.00199	0.00806	CbGeAlD
Furosemide—SLC22A8—brain—amyotrophic lateral sclerosis	0.00198	0.00802	CbGeAlD
Furosemide—CA2—central nervous system—amyotrophic lateral sclerosis	0.00191	0.00776	CbGeAlD
Furosemide—CA2—cerebellum—amyotrophic lateral sclerosis	0.00187	0.00759	CbGeAlD
Furosemide—SLC22A5—cerebellum—amyotrophic lateral sclerosis	0.00184	0.00746	CbGeAlD
Furosemide—CA4—brain—amyotrophic lateral sclerosis	0.00183	0.00743	CbGeAlD
Furosemide—CA2—brain—amyotrophic lateral sclerosis	0.00152	0.00616	CbGeAlD
Furosemide—SLC22A5—brain—amyotrophic lateral sclerosis	0.00149	0.00606	CbGeAlD
Furosemide—Bumetanide—PTGS2—amyotrophic lateral sclerosis	0.000759	1	CrCbGaD
Furosemide—SLC22A11—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000698	0.00532	CbGpPWpGaD
Furosemide—CA6—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000697	0.00531	CbGpPWpGaD
Furosemide—CA5A—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000697	0.00531	CbGpPWpGaD
Furosemide—SLC22A5—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000692	0.00528	CbGpPWpGaD
Furosemide—ALB—Platelet degranulation—PFN1—amyotrophic lateral sclerosis	0.000675	0.00515	CbGpPWpGaD
Furosemide—PGD—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000672	0.00512	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.000669	0.0051	CbGpPWpGaD
Furosemide—CA14—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000665	0.00507	CbGpPWpGaD
Furosemide—CA12—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000659	0.00502	CbGpPWpGaD
Furosemide—CA12—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000659	0.00502	CbGpPWpGaD
Furosemide—CA5B—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00065	0.00496	CbGpPWpGaD
Furosemide—CA7—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00065	0.00496	CbGpPWpGaD
Furosemide—CA6—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000648	0.00494	CbGpPWpGaD
Furosemide—CA5A—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000648	0.00494	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000647	0.00493	CbGpPWpGaD
Furosemide—ALB—Response to elevated platelet cytosolic Ca2+—PFN1—amyotrophic lateral sclerosis	0.000644	0.0049	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000635	0.00484	CbGpPWpGaD
Furosemide—SLC22A8—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000626	0.00477	CbGpPWpGaD
Furosemide—PGD—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000625	0.00476	CbGpPWpGaD
Furosemide—CA14—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000625	0.00476	CbGpPWpGaD
Furosemide—SLC22A11—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000622	0.00474	CbGpPWpGaD
Furosemide—CA5A—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000609	0.00464	CbGpPWpGaD
Furosemide—CA6—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000609	0.00464	CbGpPWpGaD
Furosemide—ABCC2—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.000609	0.00464	CbGpPWpGaD
Furosemide—CA5B—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000605	0.00461	CbGpPWpGaD
Furosemide—CA7—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000605	0.00461	CbGpPWpGaD
Furosemide—CA12—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000603	0.00459	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000595	0.00453	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000595	0.00453	CbGpPWpGaD
Furosemide—SLC22A5—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000589	0.00449	CbGpPWpGaD
Furosemide—PGD—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000588	0.00448	CbGpPWpGaD
Furosemide—CA1—C-MYB transcription factor network—PTGS2—amyotrophic lateral sclerosis	0.000579	0.00441	CbGpPWpGaD
Furosemide—CA7—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000569	0.00433	CbGpPWpGaD
Furosemide—CA5B—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000569	0.00433	CbGpPWpGaD
Furosemide—CA14—Metabolism—DAO—amyotrophic lateral sclerosis	0.000565	0.00431	CbGpPWpGaD
Furosemide—CA12—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00056	0.00427	CbGpPWpGaD
Furosemide—CA5A—Metabolism—DAO—amyotrophic lateral sclerosis	0.000551	0.0042	CbGpPWpGaD
Furosemide—CA6—Metabolism—DAO—amyotrophic lateral sclerosis	0.000551	0.0042	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000546	0.00416	CbGpPWpGaD
Furosemide—SLC22A8—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000532	0.00406	CbGpPWpGaD
Furosemide—PGD—Disease—CHMP2B—amyotrophic lateral sclerosis	0.000532	0.00405	CbGpPWpGaD
Furosemide—PGD—Metabolism—DAO—amyotrophic lateral sclerosis	0.000531	0.00405	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00053	0.00404	CbGpPWpGaD
Furosemide—ALB—Lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	0.000528	0.00403	CbGpPWpGaD
Furosemide—CA12—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000527	0.00401	CbGpPWpGaD
Furosemide—CA4—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000525	0.004	CbGpPWpGaD
Furosemide—CA4—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000525	0.004	CbGpPWpGaD
Furosemide—SLC22A5—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000525	0.004	CbGpPWpGaD
Furosemide—SLC22A6—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000523	0.00398	CbGpPWpGaD
Furosemide—CA7—Metabolism—DAO—amyotrophic lateral sclerosis	0.000514	0.00392	CbGpPWpGaD
Furosemide—CA5B—Metabolism—DAO—amyotrophic lateral sclerosis	0.000514	0.00392	CbGpPWpGaD
Furosemide—CA2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000504	0.00384	CbGpPWpGaD
Furosemide—CA2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000504	0.00384	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000494	0.00376	CbGpPWpGaD
Furosemide—CA9—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	0.000486	0.00371	CbGpPWpGaD
Furosemide—CA1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000483	0.00368	CbGpPWpGaD
Furosemide—CA1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000483	0.00368	CbGpPWpGaD
Furosemide—PGD—Disease—PLB1—amyotrophic lateral sclerosis	0.000481	0.00366	CbGpPWpGaD
Furosemide—CA4—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000481	0.00366	CbGpPWpGaD
Furosemide—CA12—Metabolism—DAO—amyotrophic lateral sclerosis	0.000476	0.00363	CbGpPWpGaD
Furosemide—SLC22A8—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000475	0.00362	CbGpPWpGaD
Furosemide—ABCC2—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000469	0.00358	CbGpPWpGaD
Furosemide—ALB—Vitamin B12 Metabolism—SOD1—amyotrophic lateral sclerosis	0.000468	0.00357	CbGpPWpGaD
Furosemide—CA2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000461	0.00351	CbGpPWpGaD
Furosemide—CA4—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000447	0.0034	CbGpPWpGaD
Furosemide—SLC22A6—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000444	0.00339	CbGpPWpGaD
Furosemide—CA1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000442	0.00337	CbGpPWpGaD
Furosemide—PGD—Disease—VCP—amyotrophic lateral sclerosis	0.000429	0.00327	CbGpPWpGaD
Furosemide—CA2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000428	0.00326	CbGpPWpGaD
Furosemide—CA14—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000428	0.00326	CbGpPWpGaD
Furosemide—CA9—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000425	0.00324	CbGpPWpGaD
Furosemide—CA9—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000425	0.00324	CbGpPWpGaD
Furosemide—CA4—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00042	0.0032	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000417	0.00318	CbGpPWpGaD
Furosemide—CA6—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000417	0.00318	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000417	0.00318	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000412	0.00314	CbGpPWpGaD
Furosemide—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—amyotrophic lateral sclerosis	0.000411	0.00314	CbGpPWpGaD
Furosemide—CA1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000411	0.00313	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—SOD1—amyotrophic lateral sclerosis	0.000403	0.00307	CbGpPWpGaD
Furosemide—PGD—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000403	0.00307	CbGpPWpGaD
Furosemide—CA2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000403	0.00307	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000399	0.00304	CbGpPWpGaD
Furosemide—SLC22A6—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000396	0.00302	CbGpPWpGaD
Furosemide—CA14—Metabolism—GSR—amyotrophic lateral sclerosis	0.000395	0.00301	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—GSTP1—amyotrophic lateral sclerosis	0.000393	0.003	CbGpPWpGaD
Furosemide—CA7—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00039	0.00297	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00039	0.00297	CbGpPWpGaD
Furosemide—CA9—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000388	0.00296	CbGpPWpGaD
Furosemide—CA1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000386	0.00294	CbGpPWpGaD
Furosemide—CA6—Metabolism—GSR—amyotrophic lateral sclerosis	0.000385	0.00294	CbGpPWpGaD
Furosemide—CA5A—Metabolism—GSR—amyotrophic lateral sclerosis	0.000385	0.00294	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—SOD1—amyotrophic lateral sclerosis	0.000381	0.0029	CbGpPWpGaD
Furosemide—CA4—Metabolism—DAO—amyotrophic lateral sclerosis	0.00038	0.00289	CbGpPWpGaD
Furosemide—PGD—Metabolism—GSR—amyotrophic lateral sclerosis	0.000372	0.00283	CbGpPWpGaD
Furosemide—ABCC2—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000367	0.0028	CbGpPWpGaD
Furosemide—CA2—Metabolism—DAO—amyotrophic lateral sclerosis	0.000364	0.00278	CbGpPWpGaD
Furosemide—CA9—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000361	0.00275	CbGpPWpGaD
Furosemide—CA12—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000361	0.00275	CbGpPWpGaD
Furosemide—CA5B—Metabolism—GSR—amyotrophic lateral sclerosis	0.00036	0.00274	CbGpPWpGaD
Furosemide—CA7—Metabolism—GSR—amyotrophic lateral sclerosis	0.00036	0.00274	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000355	0.0027	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000355	0.0027	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000352	0.00268	CbGpPWpGaD
Furosemide—ALB—Lipid and lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	0.000351	0.00267	CbGpPWpGaD
Furosemide—CA1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000349	0.00266	CbGpPWpGaD
Furosemide—ALB—Vitamin B12 Metabolism—APOE—amyotrophic lateral sclerosis	0.000345	0.00263	CbGpPWpGaD
Furosemide—CA9—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000339	0.00259	CbGpPWpGaD
Furosemide—CA12—Metabolism—GSR—amyotrophic lateral sclerosis	0.000333	0.00254	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	0.000333	0.00254	CbGpPWpGaD
Furosemide—ALB—Platelet degranulation—SOD1—amyotrophic lateral sclerosis	0.000327	0.00249	CbGpPWpGaD
Furosemide—CA14—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000325	0.00247	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000318	0.00242	CbGpPWpGaD
Furosemide—CA6—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000316	0.00241	CbGpPWpGaD
Furosemide—CA5A—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000316	0.00241	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000316	0.00241	CbGpPWpGaD
Furosemide—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—amyotrophic lateral sclerosis	0.000311	0.00237	CbGpPWpGaD
Furosemide—PGD—Disease—CST3—amyotrophic lateral sclerosis	0.000308	0.00234	CbGpPWpGaD
Furosemide—CA9—Metabolism—DAO—amyotrophic lateral sclerosis	0.000307	0.00234	CbGpPWpGaD
Furosemide—PGD—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000305	0.00233	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000303	0.00231	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	0.0003	0.00228	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000299	0.00228	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000299	0.00228	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000297	0.00227	CbGpPWpGaD
Furosemide—CA7—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000295	0.00225	CbGpPWpGaD
Furosemide—CA5B—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000295	0.00225	CbGpPWpGaD
Furosemide—CA4—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000288	0.00219	CbGpPWpGaD
Furosemide—CA2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000276	0.0021	CbGpPWpGaD
Furosemide—CA12—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000274	0.00208	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000272	0.00207	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000272	0.00207	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000271	0.00206	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000271	0.00206	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000267	0.00203	CbGpPWpGaD
Furosemide—CA4—Metabolism—GSR—amyotrophic lateral sclerosis	0.000266	0.00202	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000266	0.00202	CbGpPWpGaD
Furosemide—CA1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000265	0.00202	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000257	0.00196	CbGpPWpGaD
Furosemide—CA2—Metabolism—GSR—amyotrophic lateral sclerosis	0.000255	0.00194	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000253	0.00193	CbGpPWpGaD
Furosemide—ALB—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.000247	0.00189	CbGpPWpGaD
Furosemide—CA1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000244	0.00186	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000241	0.00184	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000238	0.00181	CbGpPWpGaD
Furosemide—CA9—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000233	0.00177	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000231	0.00176	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000226	0.00172	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000226	0.00172	CbGpPWpGaD
Furosemide—PGD—Disease—CASP9—amyotrophic lateral sclerosis	0.000224	0.0017	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000219	0.00167	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000219	0.00167	CbGpPWpGaD
Furosemide—CA4—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000218	0.00166	CbGpPWpGaD
Furosemide—CA9—Metabolism—GSR—amyotrophic lateral sclerosis	0.000215	0.00164	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000214	0.00163	CbGpPWpGaD
Furosemide—CA2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000209	0.00159	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000206	0.00157	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000201	0.00153	CbGpPWpGaD
Furosemide—CA1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000201	0.00153	CbGpPWpGaD
Furosemide—ALB—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	0.000199	0.00152	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000195	0.00149	CbGpPWpGaD
Furosemide—PGD—Disease—ERBB4—amyotrophic lateral sclerosis	0.000191	0.00146	CbGpPWpGaD
Furosemide—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	0.00019	0.00145	CbGpPWpGaD
Furosemide—CA9—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000176	0.00134	CbGpPWpGaD
Furosemide—CA14—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000174	0.00133	CbGpPWpGaD
Furosemide—ALB—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.000172	0.00131	CbGpPWpGaD
Furosemide—CA5A—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.00017	0.0013	CbGpPWpGaD
Furosemide—CA6—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.00017	0.0013	CbGpPWpGaD
Furosemide—PGD—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000164	0.00125	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000163	0.00124	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—VEGFA—amyotrophic lateral sclerosis	0.00016	0.00122	CbGpPWpGaD
Furosemide—CA14—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00016	0.00122	CbGpPWpGaD
Furosemide—ALB—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.000159	0.00122	CbGpPWpGaD
Furosemide—CA7—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000159	0.00121	CbGpPWpGaD
Furosemide—CA5B—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000159	0.00121	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000156	0.00119	CbGpPWpGaD
Furosemide—CA6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000156	0.00119	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.000154	0.00118	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000153	0.00117	CbGpPWpGaD
Furosemide—PGD—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000151	0.00115	CbGpPWpGaD
Furosemide—PGD—Disease—APOE—amyotrophic lateral sclerosis	0.000148	0.00113	CbGpPWpGaD
Furosemide—CA12—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000147	0.00112	CbGpPWpGaD
Furosemide—CA7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000146	0.00111	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000146	0.00111	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.000145	0.0011	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000138	0.00105	CbGpPWpGaD
Furosemide—CA12—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000135	0.00103	CbGpPWpGaD
Furosemide—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000132	0.00101	CbGpPWpGaD
Furosemide—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000132	0.00101	CbGpPWpGaD
Furosemide—CA14—Metabolism—APOE—amyotrophic lateral sclerosis	0.000132	0.00101	CbGpPWpGaD
Furosemide—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	0.00013	0.000991	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.00013	0.00099	CbGpPWpGaD
Furosemide—CA5A—Metabolism—APOE—amyotrophic lateral sclerosis	0.000129	0.00098	CbGpPWpGaD
Furosemide—CA6—Metabolism—APOE—amyotrophic lateral sclerosis	0.000129	0.00098	CbGpPWpGaD
Furosemide—PGD—Metabolism—APOE—amyotrophic lateral sclerosis	0.000124	0.000945	CbGpPWpGaD
Furosemide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	0.000124	0.000944	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000123	0.000941	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—TP53—amyotrophic lateral sclerosis	0.000121	0.000924	CbGpPWpGaD
Furosemide—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000121	0.000923	CbGpPWpGaD
Furosemide—CA5B—Metabolism—APOE—amyotrophic lateral sclerosis	0.00012	0.000914	CbGpPWpGaD
Furosemide—CA7—Metabolism—APOE—amyotrophic lateral sclerosis	0.00012	0.000914	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000117	0.000895	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000117	0.000895	CbGpPWpGaD
Furosemide—CA4—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000117	0.000894	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	0.000115	0.000874	CbGpPWpGaD
Furosemide—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000113	0.000858	CbGpPWpGaD
Furosemide—CA2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000112	0.000857	CbGpPWpGaD
Furosemide—CA12—Metabolism—APOE—amyotrophic lateral sclerosis	0.000111	0.000847	CbGpPWpGaD
Furosemide—CA1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000108	0.000821	CbGpPWpGaD
Furosemide—CA4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000108	0.000821	CbGpPWpGaD
Furosemide—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000106	0.000807	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000105	0.000797	CbGpPWpGaD
Furosemide—CA2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000103	0.000787	CbGpPWpGaD
Furosemide—PGD—Disease—PTGS2—amyotrophic lateral sclerosis	0.000101	0.000773	CbGpPWpGaD
Furosemide—CA1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.9e-05	0.000755	CbGpPWpGaD
Furosemide—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	9.57e-05	0.000729	CbGpPWpGaD
Furosemide—CA9—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.47e-05	0.000722	CbGpPWpGaD
Furosemide—CA14—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.04e-05	0.000689	CbGpPWpGaD
Furosemide—CA4—Metabolism—APOE—amyotrophic lateral sclerosis	8.87e-05	0.000676	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	8.83e-05	0.000673	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.81e-05	0.000671	CbGpPWpGaD
Furosemide—CA6—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.81e-05	0.000671	CbGpPWpGaD
Furosemide—CA9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.71e-05	0.000664	CbGpPWpGaD
Furosemide—CA2—Metabolism—APOE—amyotrophic lateral sclerosis	8.5e-05	0.000648	CbGpPWpGaD
Furosemide—PGD—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.5e-05	0.000648	CbGpPWpGaD
Furosemide—CA7—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.22e-05	0.000627	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.22e-05	0.000627	CbGpPWpGaD
Furosemide—CA1—Metabolism—APOE—amyotrophic lateral sclerosis	8.15e-05	0.000621	CbGpPWpGaD
Furosemide—CA12—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.62e-05	0.00058	CbGpPWpGaD
Furosemide—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	7.47e-05	0.000569	CbGpPWpGaD
Furosemide—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	7.25e-05	0.000553	CbGpPWpGaD
Furosemide—CA9—Metabolism—APOE—amyotrophic lateral sclerosis	7.16e-05	0.000546	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	6.7e-05	0.00051	CbGpPWpGaD
Furosemide—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	6.69e-05	0.00051	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	6.1e-05	0.000465	CbGpPWpGaD
Furosemide—CA4—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.07e-05	0.000463	CbGpPWpGaD
Furosemide—CA2—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.82e-05	0.000444	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	5.77e-05	0.00044	CbGpPWpGaD
Furosemide—CA1—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.58e-05	0.000426	CbGpPWpGaD
Furosemide—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	5.5e-05	0.000419	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	5.02e-05	0.000382	CbGpPWpGaD
Furosemide—CA9—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.91e-05	0.000374	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	4.55e-05	0.000347	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.44e-05	0.000262	CbGpPWpGaD
Furosemide—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2.97e-05	0.000227	CbGpPWpGaD
Furosemide—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.95e-05	0.000225	CbGpPWpGaD
Furosemide—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.72e-05	0.000207	CbGpPWpGaD
Furosemide—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	2.25e-05	0.000171	CbGpPWpGaD
Furosemide—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	2.23e-05	0.00017	CbGpPWpGaD
Furosemide—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.53e-05	0.000117	CbGpPWpGaD
